Panbela Therapeutics

PBLA · OTC

$0.001+$0.00 (+0.00%)TodayMarket closed · Oct 19, 3:11 PM ET

Prev close $0.001

Latest news

Press releaseNov 14, 4:10 PM ETGlobe Newswire
Panbela Provides Business Update and Reports Q3 2024 Financial Results
Press releaseOct 31, 8:00 AM ETGlobe Newswire
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024
Press releaseSep 24, 8:00 AM ETGlobe Newswire
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
Press releaseAug 13, 4:10 PM ETGlobe Newswire
Panbela Provides Business Update and Reports Q2 2024 Financial Results
Press releaseJul 30, 4:15 PM ETGlobe Newswire
Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Panbela Provides Business Update and Reports Q3 2024 Financial Results

Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center

Panbela Provides Business Update and Reports Q2 2024 Financial Results

Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024